Company: TVRD
Filing Date: 2025-03-24
Form Type: 8-K
Source: 0001104659-25-027233
Chunk: 4

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-03-24
Form: 8-K
Item: Item 8.01
Chunk 4
---
 prospectus filed on February 14, 2025, or the Form 424 Prospectus, omitted or misrepresented
material information regarding the Merger, rendering the Form 424 Prospectus false and misleading. In addition, as of March 24,
2025, Cara has received thirteen demand letters and three draft complaints from purported stockholders relating to the proposed Merger,
the Contemplated Transactions and the disclosures contained in this proxy statement/prospectus. Responding to these demands and litigation
often is expensive and diverts management’s attention and resources, which could adversely affect the combined company’s business.

  The following disclosure replaces the first paragraph under the risk factor titled “[l]awsuits                                            
  may be filed against Cara and the members of the Cara Board arising out of the Merger, which may delay or prevent the proposed merger.,”  
  on page 37 of the proxy statement/prospectus:                                                                                             
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

Putative
stockholder complaints, including stockholder class action complaints, and other complaints may be filed against Cara, the Cara Board,
Tvardi, the Tvardi Board and others in connection with the transactions contemplated by the Merger Agreement. As of March 24,
2025, t wo lawsuits were filed in the Supreme Court of the State of New York, County of New York on March 5 and March 6,
2025 by two purported stockholders of Cara in connection with the Merger. Each Complaint named as defendants Cara and the members of the
Cara board of directors. The plaintiffs contended that the Form 424 prospectus filed on February 14, 2025, or the Form 424
Prospectus, omitted or misrepresented material information regarding the Merger, rendering the Form 424 Prospectus false and misleading.
In addition, as of March 24, 2025, Cara has received thirteen demand letters and three draft complaints from purported stockholders
relating to the proposed Merger, the Contemplated Transactions and the disclosures contained in this proxy statement/prospectus. The outcome
of litigation is uncertain, and Cara may not be successful in defending against any current orfuture claims. Lawsuits that may
be filed against Cara, the Cara Board, Tvardi or the Tvardi Board could delay or prevent the merger, divert the attention of Cara’s
management and employees from Cara’s day-to-day business and otherwise adversely affect Cara’s